You searched for "innovation"
RCOphth Annual Congress 2022 - Preview
19 May 2022
Eye News previews the RCOphth Annual Congress 2022, as we look forward to the return of an in-person Congress for the first time since 2019. Follow updates and key events here.
Retinoblastoma mortality associations with choroidal and optic nerve invasion
The authors present a retrospective cohort study. Data was extracted from the National Cancer Institute’s Surveillance Epidemiology and End Results (SEER) database, based in the US and founded in 1973. Cases of retinoblastoma were extracted using the inclusion criteria of...
Minimally Invasive Glaucoma Surgery – A Practical Guide
1 October 2017
| Indira Madgula
|
EYE - Glaucoma
The treatment of patients with mild to moderate glaucoma has evolved rapidly in the last decade. Traditionally, medical and laser treatments were the mainstay of therapy for this group of patients. Trabeculectomy, non-penetrating surgery and glaucoma drainage implants were reserved...
Risk factors for lens dislocation post cataract surgery
This retrospective cohort study in Korea assessed the risk factors for intraocular lens (IOL) dislocation. They used national data of 2,162,191 patients who had had cataract surgery between 2009 and 2016. They excluded any patient who had an IOL dislocation...2018/19 Ophthalmology Honours results announced
13 March 2019
Recipients of the 2018/19 Ophthalmology Honours by Bayer were recognised during a presentation held at BMA House, London.
Mainline Instruments Appointed Distributor Partner by InMode for Envision
27 February 2025
|
Contracts & Distributors
Mainline Instruments is excited to announce a new partnership with InMode, a globally recognised leader in IPL, Laser, and Radiofrequency medical technologies, to distribute their prestigious Envision Dry Eye care platform throughout the UK and Ireland. InMode is known for...
Should we work together to identify congenital nasolacrimal duct obstruction and otitis media?
The authors present a retrospective medical notes review. The aim of the study was to establish how common tympanostomy tube (T-tube) insertion is in children needing probe and intubation (P&I) for congenital nasolacrimal duct obstruction (CNLDO). All cases of CNLDO...Stoke Hospital commemorates fifth anniversary
CHEC marks five year milestone with community celebration.My Top Five: Emerging technologies revolutionising ophthalmology
3 October 2024
| Khaled Saqqaw
|
EYE - Vitreo-Retinal, EYE - Cataract, EYE - Refractive, EYE - Cornea
Advancements in ophthalmology have significantly transformed eyecare practices. This article explores five emerging technologies that are revolutionising the field, from virtual reality (VR) surgical training to novel therapies for corneal conditions. These innovations are reshaping how eyecare professionals diagnose, treat...
Fight for Sight to maximise impact by funding solutions-focused research in priority eye conditions
1 August 2018
| Rod McNeil
|
EYE - General
Fight for Sight aims to stop sight loss by funding pioneering research. Rod McNeil takes a look at the Primer Fellowship Awards programme, which provides funding for up to £60,000 for individuals to undertake vision-related research for one year. Among...
Retinoblastoma chemotherapeutic drugs and their toxic effects on RPE cells
1 October 2016
| Bheemanagouda Patil
|
EYE - Vitreo-Retinal
There is reported clinical evidence of retinal pigment epithelium (RPE) alterations after intra-arterial (IAC) and intravitreal chemotherapy (IViC) of retinoblastoma. The purpose of this study was to investigate the cellular toxic effects of melphalan, topotecan and carboplatin on the RPE...
Stem cell therapy for Parkinson’s disease: researching for an effective cure
1 December 2015
| Romina Vuono
|
EYE - Neuro-ophthalmology
Neurodegenerative diseases are characterised by the chronic and progressive loss of neurons, which in turn results in loss of cognitive and physical functions. The World Health Organization has estimated that the disability-adjusted life years lost from neurological disease was about...
